DB
MLAB icon

Dmitry Balyasny’s Mesa Laboratories MLAB Stock Holding History

Dmitry Balyasny’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,792
Closed -$298K – 3268
2025
Q4 		$298K Sell
3,792
-180
-5% -$13.7K ﹤0.01% 2727
2025
Q3 		$266K Buy
+3,972
New +$286K ﹤0.01% 2623
2023
Q3 		– Sell
-5,850
Closed -$752K – 2545
2023
Q2 		$752K Buy
5,850
+3,264
+126% +$497K ﹤0.01% 1731
2023
Q1 		$452K Buy
+2,586
New +$463K ﹤0.01% 1977
2022
Q4 		– Sell
-4,338
Closed -$611K – 3051
2022
Q3 		$611K Buy
4,338
+1,751
+68% +$319K ﹤0.01% 1978
2022
Q2 		$528K Buy
2,587
+422
+19% +$92.4K ﹤0.01% 1958
2022
Q1 		$552K Buy
2,165
+129
+6% +$35K ﹤0.01% 1794
2021
Q4 		$668K Buy
2,036
+855
+72% +$268K ﹤0.01% 1549
2021
Q3 		$357K Sell
1,181
-218
-16% -$62K ﹤0.01% 1549
2021
Q2 		$379K Sell
1,399
-1,066
-43% -$270K ﹤0.01% 1604
2021
Q1 		$600K Sell
2,465
-297
-11% -$81.7K ﹤0.01% 1365
2020
Q4 		$792K Buy
+2,762
New +$760K ﹤0.01% 1061
2020
Q2 		– Sell
-1,107
Closed -$250K – 1360
2020
Q1 		$250K Sell
1,107
-1,874
-63% -$462K ﹤0.01% 1016
2019
Q4 		$743K Buy
+2,981
New +$698K ﹤0.01% 937

Other funds holding MLAB

LPP
Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Dmitry Balyasny's MLAB Position: Q1 2026 in Review

Dmitry Balyasny sold out of Mesa Laboratories (MLAB) in Q1 2026, closing a stake of 3,792 shares — an estimated $298K sold.

Dmitry Balyasny first reported a position in MLAB in Q4 2019 and held it in 14 quarters. The position peaked at $792K in Q4 2020. 161 funds tracked by Wall St. Rank hold MLAB as of Q1 2026.

  • Dmitry Balyasny reported no remaining Mesa Laboratories position as of Q1 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 3,792 Mesa Laboratories shares in Q1 2026, an estimated $298K.
  • Dmitry Balyasny first reported a position in Mesa Laboratories in Q4 2019 and held it in 14 quarters.
  • Dmitry Balyasny's Mesa Laboratories position peaked at $792K in Q4 2020.
  • 161 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.